Hvis påkrævet kan doseringen nedsættes (fra bexaroten 300 mg/ m2 / dag til 200 mg/ m2 / dag, og til 100 mg/ m2 / dag, i fald det er nødvendigt), eller terapien kan afbrydes.
If fasting triglycerides are elevated or become elevated during treatment, institution of antilipaemic therapy is recommended, and if necessary, dose reductions (from 300 mg/ m2/ day of bexarotene to 200 mg/ m2/ day, and if necessary to 100 mg/ m2/ day) or treatment discontinuation.